JP2024509877A - 組換えタンパク質の精製方法 - Google Patents

組換えタンパク質の精製方法 Download PDF

Info

Publication number
JP2024509877A
JP2024509877A JP2023554343A JP2023554343A JP2024509877A JP 2024509877 A JP2024509877 A JP 2024509877A JP 2023554343 A JP2023554343 A JP 2023554343A JP 2023554343 A JP2023554343 A JP 2023554343A JP 2024509877 A JP2024509877 A JP 2024509877A
Authority
JP
Japan
Prior art keywords
chromatography
column
pool
protein
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023554343A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024509877A5 (https=
JPWO2022192504A5 (https=
Inventor
ソイス,ニール
コナー,ジェレミー・エス
ハンター,グレン・エム
ショーメイカー,ケネス
ワイリー,ブレット
フリン,ジョン・ビー
ケイオニル,ナコーン
グエン,トゥイ・エヌ
シン,シッダールタ
Original Assignee
アムジエン・インコーポレーテツド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アムジエン・インコーポレーテツド filed Critical アムジエン・インコーポレーテツド
Publication of JP2024509877A publication Critical patent/JP2024509877A/ja
Publication of JP2024509877A5 publication Critical patent/JP2024509877A5/ja
Publication of JPWO2022192504A5 publication Critical patent/JPWO2022192504A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/36Extraction; Separation; Purification by a combination of two or more processes of different types
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/10Selective adsorption, e.g. chromatography characterised by constructional or operational features
    • B01D15/18Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns
    • B01D15/1864Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns
    • B01D15/1885Selective adsorption, e.g. chromatography characterised by constructional or operational features relating to flow patterns using two or more columns placed in parallel
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3804Affinity chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8831Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving peptides or proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/60Construction of the column
    • G01N30/6034Construction of the column joining multiple columns

Landscapes

  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2023554343A 2021-03-10 2022-03-10 組換えタンパク質の精製方法 Pending JP2024509877A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163159217P 2021-03-10 2021-03-10
US63/159,217 2021-03-10
PCT/US2022/019697 WO2022192504A1 (en) 2021-03-10 2022-03-10 Methods for purification of recombinant proteins

Publications (3)

Publication Number Publication Date
JP2024509877A true JP2024509877A (ja) 2024-03-05
JP2024509877A5 JP2024509877A5 (https=) 2025-03-10
JPWO2022192504A5 JPWO2022192504A5 (https=) 2025-03-10

Family

ID=80952165

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023554343A Pending JP2024509877A (ja) 2021-03-10 2022-03-10 組換えタンパク質の精製方法

Country Status (9)

Country Link
US (1) US20240051990A1 (https=)
EP (1) EP4305048A1 (https=)
JP (1) JP2024509877A (https=)
KR (1) KR20230154908A (https=)
CN (1) CN117043173A (https=)
AU (1) AU2022234768A1 (https=)
CA (1) CA3209216A1 (https=)
IL (1) IL304571A (https=)
WO (1) WO2022192504A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2024235093A1 (en) * 2023-03-14 2025-09-04 Amgen Inc. Anion exchange chromatography processes using a primary amine ligand
US20240426793A1 (en) * 2023-06-20 2024-12-26 Amgen Inc. Methods for chromatography and chromatography medium reuse
WO2025262319A1 (en) * 2024-06-21 2025-12-26 Boehringer Ingelheim International Gmbh Modifying blue color formation in bioprocesses

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015520667A (ja) * 2012-04-23 2015-07-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung クロマトグラフィー法
JP2016510981A (ja) * 2013-03-08 2016-04-14 ジェンザイム・コーポレーション 治療用タンパク質の連続的な精製

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302070B6 (cs) 1998-04-21 2010-09-29 Micromet Ag Jednoretezcový multifunkcní polypeptid, polynukleotid, vektor obsahující tento polynukleotid, bunka transfekovaná tímto polynukleotidem, prostredek obsahující tento polypeptid, polynukleotid nebo vektor a jejich použití a zpusob identifikace aktiváto
DE602004030811D1 (de) 2003-10-16 2011-02-10 Micromet Ag Multispezifische deimmunisierte cd3-bindende moleküle
RS53008B2 (sr) 2007-04-03 2022-12-30 Amgen Res Munich Gmbh Interspecijski specifičan cd3-epsilon vezujući domen
EP2820047B1 (en) 2012-03-01 2018-04-25 Amgen Research (Munich) GmbH Long life polypeptide binding molecules
US20140302037A1 (en) 2013-03-15 2014-10-09 Amgen Inc. BISPECIFIC-Fc MOLECULES
AU2014236769B2 (en) 2013-03-15 2018-09-27 Amgen Inc. Heterodimeric bispecific antibodies
US20140308285A1 (en) 2013-03-15 2014-10-16 Amgen Inc. Heterodimeric bispecific antibodies
WO2014140358A1 (en) 2013-03-15 2014-09-18 Amgen Research (Munich) Gmbh Single chain binding molecules comprising n-terminal abp
EP3733710A1 (en) 2013-09-25 2020-11-04 Amgen, Inc Hetrodimeric v-c-fc-v-c antibody
EA039859B1 (ru) 2015-07-31 2022-03-21 Эмджен Рисерч (Мюник) Гмбх Биспецифические конструкты антител, связывающие egfrviii и cd3

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015520667A (ja) * 2012-04-23 2015-07-23 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung クロマトグラフィー法
JP2016510981A (ja) * 2013-03-08 2016-04-14 ジェンザイム・コーポレーション 治療用タンパク質の連続的な精製

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
JOURNAL OF CHROMATOGRAPHY A, vol. 1579, JPN6026004092, 2018, pages 60 - 72, ISSN: 0005787837 *

Also Published As

Publication number Publication date
US20240051990A1 (en) 2024-02-15
CA3209216A1 (en) 2022-09-15
EP4305048A1 (en) 2024-01-17
AU2022234768A1 (en) 2023-07-27
IL304571A (en) 2023-09-01
KR20230154908A (ko) 2023-11-09
WO2022192504A1 (en) 2022-09-15
CN117043173A (zh) 2023-11-10

Similar Documents

Publication Publication Date Title
AU2020216108B2 (en) A continuous manufacturing process for biologics manufacturing by integration of drug substance and drug product processes
US20240051990A1 (en) Methods for purification of recombinant proteins
US20240075406A1 (en) Parallel chromatography systems and methods
CA3072129A1 (en) Method for purifying proteins
US20230058276A1 (en) Methods for harvesting biomolecules
US20260070943A1 (en) A method for harvesting products from high cell density perfusion cell cultures
US20230416667A1 (en) In-process verification of calibration status of ph probes
US20250288957A1 (en) Intensified ultrafiltration/diafiltration processes
WO2025251034A1 (en) Purification method
HK40119367A (zh) 通过将药物物质和药物产品过程整体化的生物制剂制造的连续制造过程
EA049616B1 (ru) Непрерывный способ изготовления биопрепаратов посредством интеграции процессов получения лекарственного вещества и лекарственного препарата
HK40057745A (en) Automated biomanufacturing systems, facilities, and processes

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250228

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250228

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20260130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260203